Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Psychopharmacology and Neuroscience Année : 2022

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later

Francois Radiguer

Dates et versions

hal-04520462 , version 1 (25-03-2024)

Identifiants

Citer

Matthieu Gasnier, Walid Choucha, David Montani, Nicolas Noël, Céline Verstuyft, et al.. Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later. Clinical Psychopharmacology and Neuroscience, 2022, 20 (4), pp.762-767. ⟨10.9758/cpn.2022.20.4.762⟩. ⟨hal-04520462⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More